Get to know our client

Evox Therapeutics is a biotechnology company focused on transforming the treatment of severe neurodegenerative diseases through advanced genetic medicine and next-generation genome editing technologies. The company is developing an innovative pipeline targeting conditions such as Huntington’s disease, ALS, and Spinocerebellar Ataxia Type 2 (SCA2), while exploring broader applications across both genetic and non-genetic central nervous system disorders. By leveraging its proprietary exosome-based delivery platform and gene editing technologies, Evox aims to expand the reach of genetic medicine into the brain, enabling safer, more effective, and commercially scalable treatments for patients with complex neurological conditions.

Main Scope of Works

  • Design and refurbishment of existing open plan area into a new laboratories

  • Modification and upgrade of HVAC plant and equipment to meet laboratory standards

  • Installation of Class 2 Bio-Safety Cabinets

  • Roller Storage Units

  • Existing CO2 Special Gases System Modification

  • New N2 & O2 Special Gases System Installation

In 2019, iab-Lab was appointed by Evox Therapeutics to convert an existing office and meeting room area into a Protein and Nucleic Acid-Based Therapeutics Research Laboratory, following the success and expansion of the laboratory facility iab-Lab had delivered for Evox in 2018. The project converted the existing spaces into a main open-plan laboratory, four smaller laboratories and a dedicated storeroom with roller storage units. The main laboratory accommodated two Class 2 Bio-Safety Cabinets, while two of the smaller laboratories were designed for tissue culture, each incorporating a Class 2 Bio-Safety Cabinet, tall refrigerator and CO₂ incubator.

To maximise the existing infrastructure, the office HVAC system was modified and extended to provide temperature-controlled fresh air throughout the new laboratories, requiring only one additional AC unit. New oxygen and nitrogen specialist gas systems were installed, incorporating external manifolds and internal bench-mounted regulators to provide Grade 5 purity gases. The existing CO₂ system was also extended to provide additional regulators for the client’s incubators.